| Not Yet Recruiting | A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015-A and Co-administration Essential Hypertension | Phase 1 | 2026-04-19 |
| Not Yet Recruiting | A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015-A and Co-administration Essential Hypertension | Phase 1 | 2026-04-13 |
| Not Yet Recruiting | A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015-A and Co-administration Essential Hypertension | Phase 1 | 2026-04-09 |
| Not Yet Recruiting | A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015-A and Co-administration Essential Hypertension | Phase 1 | 2026-04-02 |
| Not Yet Recruiting | A Study of BR1400-1, BR1400-2, BR1400-3, BR1400-4, and BR1400-5 in Patients With Essential Hypertension Essential Hypertension | Phase 2 | 2026-03-01 |
| Not Yet Recruiting | A Study of Bosmolisib (BR101801) in Participants With R/R PTCL. Peripheral T Cell Lymphoma | Phase 2 | 2026-02-01 |
| Recruiting | A Study of Second- and Later-line Palliative Chemotherapy in Patients With Metastatic Colorectal Cancer. Metastatic Colorectal Cancer | — | 2025-11-07 |
| Recruiting | A Study of Olanzapine in Participants With Bipolar Disorder. Bipolar Disorder | — | 2025-10-30 |
| Recruiting | A Study to Evaluate the Pharmacokinetics and Safety Between "BR3006" and Co-administration of "BR3006A", "BR30 Diabete Mellitus | Phase 1 | 2025-07-05 |
| Recruiting | A Study to Evaluate the Pharmacokinetics and Safety Between "BR3006" and Co-administration of "BR3006A", "BR30 Diabetes Mellitus | Phase 1 | 2025-07-03 |
| Recruiting | A Bioequivalence Study to Evaluate Pharmacokinetics and Safety of BR2022 and BR2022-1 in Patients With Deleter Ovarian Cancer | Phase 1 | 2025-06-17 |
| Recruiting | A Phase IV Clinical Trial to Compare the Efficacy and Safety of Metformin+Sodium-Glucose Cotransporter 2 Inhib Type 2 Diabetes | Phase 4 | 2025-06-11 |
| Recruiting | A Clinical Trial to Evaluate the Safety and Efficacy of Olanzapine Titration Schedule in Patients With Schizop Schizophrenia | Phase 2 | 2025-05-30 |
| Completed | A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1018 and Coadministration of Essential Hypertension, Primary Hypercholesterolemia | Phase 1 | 2025-05-07 |
| Recruiting | A Study to Compare and Evaluate the Pharmacokinetic Characteristics and the Safety Between Administration of B Metastatic Adenocarcinoma of the Pancreas | Phase 1 | 2025-02-24 |
| Completed | A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015 and Co-administration o Essential Hypertension | Phase 1 | 2025-01-09 |
| Completed | A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015 and Co-administration o Essential Hypertension | Phase 1 | 2025-01-05 |
| Completed | A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015 and Co-administration o Essential Hypertension | Phase 1 | 2025-01-04 |
| Completed | A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015 and Co-administration o Essential Hypertension | Phase 1 | 2025-01-03 |
| Completed | A Study to Evaluate the Pharmacokinetics and Safety Between Single Oral Administration of BR3006 and Co-admini Type 2 Diabetes | Phase 1 | 2024-12-05 |
| Completed | A Study to Evaluate the Pharmacokinetics and Safety Between Single Oral Administration of BR3006 and Co-admini Type 2 Diabetes | Phase 1 | 2024-12-01 |
| Completed | A Study to Evaluate the Pharmacokinetics and Safety of BR3409 and Co-administration of BR3409-1 and BR3409-2 i Type 2 Diabetes | Phase 1 | 2024-11-10 |
| Completed | A Study to Evaluate the Pharmacokinetics and Safety of BR3409 and Co-administration of BR3409-1 and BR3409-2 i Type 2 Diabetes | Phase 1 | 2024-11-05 |
| Completed | A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1019" and Co-administration Essential Hypertension, Type 2 Diabetes | Phase 1 | 2024-10-23 |
| Recruiting | A Study to Identify the Risk of Non-alcoholic Fatty Liver Disease (NAFLD) in Patients With Type 2 Diabetes in Type 2 Diabetes | — | 2024-09-30 |
| Completed | A Study to Evaluate the Pharmacokinetic, Pharmacodynamic Characteristics and the Safety After Administration b Essential Hypertension | Phase 1 | 2024-09-24 |
| Recruiting | A Study to Evaluate Ethanol-induced Symptoms and Safety in Breast Cancer Patients Breast Cancer | — | 2024-07-15 |
| Recruiting | A Study to Evaluate the Efficacy and Safety of BR1019A and BR1019B Combination Therapy Essential Hypertension, Type 2 Diabetes Mellitus | Phase 3 | 2024-05-21 |
| Completed | A Study to Evaluate the Efficacy and Safety of Co-administrated BR1018B and BR1018C Essential Hypertension, Primary Hypercholesterolemia | Phase 3 | 2024-04-17 |
| Recruiting | A Study to Evaluate the Efficacy and Safety of Fixed-Dose Combination of Pitavastatin/Ezetimib Primary Hypercholesterolemia, Mixed Dyslipidemia | — | 2024-03-15 |
| Completed | A Study to Compare the Pharmacokinetics and the Safety Between a Fixed-dose Combination Administration of "BR3 Type2 Diabetes Mellitus | Phase 1 | 2024-03-05 |
| Completed | A Study to Compare the Pharmacokinetics and the Safety Between a Fixed-dose Combination Administration of "BR3 Type 2 Diabetes Mellitus | Phase 1 | 2024-03-02 |
| Completed | A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1019" and Co-administration Type 2 Diabetes Mellitus, Essential Hypertension | Phase 1 | 2024-02-14 |
| Completed | A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1017-1" and Co-administrati Essential Hypertension, Primary Hypercholesterolemia | Phase 1 | 2023-12-23 |
| Recruiting | A Observational Study to Evaluate the Efficacy and Safety of Pacitol Inj. Chronic Kidney Disease 5D, Secondary Hyperparathyroidism | — | 2023-10-19 |
| Completed | A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration Hypertension | Phase 1 | 2023-09-04 |
| Recruiting | Observational Study to Evaluate the Safety and Efficacy of Zepzelca™ Injection SCLC | — | 2023-08-16 |
| Completed | A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration Hypertension | Phase 1 | 2023-08-10 |
| Recruiting | A Study to Evaluate the Efficacy and Safety of Dapagliflozin in Patient With Type 2 Diabetes Mellitus and Hype Diabetes Mellitus, Hypertension | — | 2023-07-26 |
| Completed | A Study to Evaluate Drug-drug Interactions and Safety Between "BR3006-1", "BR3006-2", and "BR3006-3" in Health Diabetes Mellitus | Phase 1 | 2023-07-22 |
| Completed | A Study to Evaluate the Pharmacokinetics and Safety Between Single Administration of "BR6002" and Coadministra Gastric or Duodenal Ulcers | Phase 1 | 2023-07-14 |
| Completed | A Study to Evaluate the Efficacy and Safety of BR1017A and BR1017B Combination Therapy in Essential Hypertensi Essential Hypertension, Primary Hypercholesterolemia | Phase 3 | 2023-07-13 |
| Completed | A Study to Evaluate the Pharmacokinetics and Safety Between Single Administration of "BR6002" and Coadministra Gastric or Duodenal Ulcer | Phase 1 | 2023-07-13 |
| Completed | A Clinical Trial Study to Evaluate the Pharmacokinetic Interaction and Safety Between BR1019-1 and BR1019-2 in Hypertension, Diabetes Mellitus, Type 2 | Phase 1 | 2023-05-13 |
| Completed | An Observational Study to Analyze the Prescription Pattern of Sugammadex and Its Effectiveness and Safety Postoperative Complications, Neuromuscular Blockade, Anesthesia | — | 2023-04-11 |
| Completed | A Study to Evaluate the Drug-drug Interaction and Safety Between "BR6001-1" and "BR6001-2" Gastric or Duodenal Ulcer | Phase 1 | 2023-03-30 |
| Completed | A Study to Evaluate the Efficacy and Safety of BR1015 Combination Therapy Essential Hypertension | Phase 3 | 2022-11-09 |
| Completed | An OS to Evaluate the Safety & Efficacy of Fixed Dose Combination Therapy With Atorvastatin and Ezetimibe Primary Hypercholesterolemia | — | 2022-09-07 |
| Completed | A Study to Evaluate the Pharmacokinetic Interaction and Safety Between BR1018-1 and BR1018-2 in Healthy Adult Hypertension, Hyperlipidemia (E.G., Hypercholesterolemia) | Phase 1 | 2022-08-04 |
| Recruiting | An OS to Evaluate Effectiveness and Safety of Fixed-dose Combinations of FMS/AML or FMS/AML/HCTZ Hypertension,Essential | — | 2022-06-23 |
| Completed | A Study to Evaluate Drug-drug Interactions Between BR1017-1 and BR1017-2 in Healthy Volunteers Hypertension, Hypercholesterinemia | Phase 1 | 2022-05-09 |
| Completed | A Study to Evaluate the Pharmacokinetics After Administration of BR3003 and Co-administration of BR3003B and B Diabetes Mellitus, Type 2 | Phase 1 | 2022-04-28 |
| Completed | A Clinical Trial to Compare the Pharmacokinetics and Safety of "BR1016C" With "BR1016D" in Healthy Volunteers Chronic Heart Failure | Phase 1 | 2021-10-27 |
| Completed | A Clinical Trial to Compare the Pharmacokinetics and Safety of "BR1016A" With "BR1016B" in Healthy Volunteers Chronic Heart Failure | Phase 1 | 2021-10-22 |
| Completed | An Observation Study to Evaluate the Renoprotective Effect of Fimasartan in Patients With DKD and Proteinuria Diabetic Kidney Disease, Proteinuria, Hypertension,Essential | — | 2021-09-29 |
| Completed | A Multi-center,Prospective, OS to Evaluate the Effectiveness of 'NAC' Nebulizer Therapy in COPD (NEWEST) Chronic Obstructive Pulmonary Disease | — | 2021-09-09 |
| Completed | A Clinical Trial to Compare the Pharmacokinetics and Bioequivalence of "BR2008" With "BR2008-1" in Healthy Vol Hepatocellular Carcinoma | Phase 1 | 2021-09-06 |
| Completed | A Clinical Trial to Evaluate Drug-drug Interactions and Safety Between "BR1015-1" and "BR1015-2" in Healthy Vo Hypertension | Phase 1 | 2021-08-16 |
| Completed | A Study to Evaluate the Efficacy and Safety of Pioglitazone 15mg or 30mg Add-on in Patients With Type 2 Diabet Type2 Diabetes | Phase 3 | 2021-05-28 |
| Completed | A Study to Compare the Pharmacokinetics and Safety Between BR9004 and BR9004-1 in Healthy Male Volunteers Prostate Cancer | Phase 1 | 2021-04-15 |
| Completed | A Multi Doses Study to Compare the Pharmacokinetics of BR9003A and BR9003 in Healthy Adult Subjects Smoking Cessation | Phase 1 | 2021-03-31 |
| Completed | A Study to Compare the Pharmacokinetics of BR9003A and BR9003 in Healthy Adult Subjects Smoking Cessation | Phase 1 | 2021-03-25 |
| Completed | Evaluate the Quality of Life and Treatment of Anxiety Symptoms of Buspirone in Patients With Depression Disord Depressive Disorder, Major, Anxiety Disorders | — | 2021-02-08 |
| Completed | Good Choice of pALliative Chemotherapy to Patient With Pancreatic Cancer ; GemcitAbine Therapy vs FOLFORINOX t Locally Advanced Pancreatic Cancer, Metastatic Pancreatic Cancer | — | 2021-01-29 |
| Completed | A Study to Evaluate Drug-drug Interactions Between BR9006-1 and BR9006-2 in Healthy Male Volunteers. Benign Prostatic Hyperplasia (BPH), Overactive Bladder | Phase 1 | 2020-07-20 |
| Completed | Docetaxel Ethanol-induced Symptoms; The Incidence and Risk Forecating Factor Breast Cancer, NSCLC, Prostate Cancer | — | 2020-06-10 |
| Completed | A Study to Compare the Pharmacokinetics of BR4002 and BR4002-1 in Healthy Volunteers Dementia Alzheimers | EARLY_Phase 1 | 2020-06-05 |
| Completed | BR101801 in Adult Patients With Advanced Hematologic Malignancies(Phase I) Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia | Phase 1 | 2020-04-21 |
| Completed | A Combination Drug Including Fimasartan and Statins in Patients With Hypertension and Dyslipidemia Hypertension and Dyslipidemia | — | 2020-04-13 |
| Active Not Recruiting | Oxaliplatin Adjuvant Chemotherapy After Curative Resection of Primary Colon Cancer Stage II Colon Cancer, Stage III Colon Cancer | — | 2020-03-25 |
| Completed | NAC Inhalation in the Treatment Of Symptomatic acuTe rhinosinUSitis Acute Rhinosinusitis, Recurrent Acute Rhinosinusitis, Chronic Rhinosinusitis | — | 2019-09-30 |
| Completed | BR1010 in Patients With Essential Hypertension Patients Who do Not Adequately Respond to Fimasartan/Amlodipine Essential Hypertension | Phase 3 | 2019-06-17 |
| Completed | VMP Regimen - Safety, Efficacy, and Optimal Dose Finding Study for Patients With Multiple Myeloma Multiple Myeloma | — | 2018-11-15 |
| Completed | To Evaluate the Pharmacokinetics and Safety of Oral Administration of BR9001 Compared With BR900A in Healthy S Rheumatoid Arthritis | Phase 1 | 2018-10-22 |
| Completed | Combination of Fimasartan/Amlodipine/Hydrochlorothiazide in Healthy Male Subjects Pharmacokinetics | Phase 1 | 2018-09-13 |
| Completed | A Clinical Trial to Evaluate the Pharmacokinetics and Safety/Tolerability of Fimasartan and Linagliptin in Hea Hypertension, Diabetes | Phase 1 | 2018-07-18 |
| Completed | FimasaRtan-basEd BP Targets After Drug SwitcHing Essential Hypertension | — | 2018-07-03 |
| Completed | A Study to Evaluate the Efficacy and Safety of Combination Treatment of Fimasartan/Atorvastatin in Patients Wi Essential Hypertension, Dyslipidemia | Phase 3 | 2018-01-15 |
| Completed | Drug Interaction Study of Fimasartan/Amlodipine/Hydrochlorothiazide in Healthy Male Subjects Drug-Drug Interaction | Phase 1 | 2017-12-15 |
| Completed | To Evaluate the Immunogenicity and Safety of Inactivated Hepatitis A Vaccine (VITHA-A) Hepatitis A Vaccine | Phase 3 | 2017-09-19 |
| Completed | A Clinical Trial to Evaluate Pharmacokinetic Interactions and Safety Between Fimasartan and Linagliptin in Hea Hypertension | Phase 1 | 2017-08-14 |
| Completed | Fimasartan Optimal Reduction Targeting Elevated Blood Pressure: the FORTE Study Hypertension | — | 2017-08-09 |
| Completed | To Evaluate the Immunogenicity and Safety of Inactivated Hepatitis A Vaccine Hepatitis A Vaccine | Phase 3 | 2017-06-20 |
| Completed | Combination of Fimasartan/Amlodipine/Rosuvastatin in Patients With Essential Hypertension and Dyslipidemia Essential Hypertension, Dyslipidemia | Phase 3 | 2017-05-29 |
| Withdrawn | A Study to Compare the Pharmacokinetics and Safety/Tolerability of BR-UPS (Ulipristal Acetate) 5 mg Tablet Wit Uterine Myoma | Phase 1 | 2017-05-19 |
| Completed | A Clinical Trial to Evaluate the Pharmacokinetics and Safety/Tolerability of Fimasartan and Atorvastatin in He Hypertension, Hyperlipidemia | Phase 1 | 2016-12-23 |
| Completed | Fimasartan and Rosuvastatin for Hypertension and Dyslipidemia Control Cardiovascular Diseases, Hyperlipidemias | — | 2016-10-11 |
| Completed | A Clinical Trial to Evaluate the Pharmacokinetics and Safety of Fimasartan and Amlodipine in Healthy Male Subj Hypertension | Phase 1 | 2016-10-01 |
| Completed | A Study to Compare the Pharmacokinetics and Safety of a Fixed Dose Combination of Fimasartan/Amlodipine/Rosuva Hypertension, Hyperlipidemia | Phase 1 | 2016-08-26 |
| Completed | Fimasartan Blood Pressure Lowering After Acute Stroke Hypertension, Ischemic Stroke, Transient Ischemic Attack | — | 2016-07-28 |
| Completed | Fimasartan in the Senior Subjects The Elderly (≥ 70 Years) With Essential Hypertension | Phase 3 | 2016-07-15 |
| Completed | A Study to Compare the Pharmacokinetics of Lafutidine and Irsogladine Maleate Tablet Gastric Ulcer | Phase 1 | 2016-04-15 |
| Completed | A Clinical Trial to Evaluate the Pharmacokinetics and Safety of Fimasartan and Rosuvastatin in Healthy Male Su Hypertension | Phase 1 | 2016-03-01 |
| Completed | A Randomized, Double-blind, Active Control, Parallel Group, Titration, Multicenter Study to Evaluate the Effic Chronic Kidney Disease | Phase 3 | 2016-02-11 |
| Completed | A Randomized, Open-label, Single-dosing, 2X2 Crossover Study to Compare the Safety and Pharmacokinetics of BR- Hepatitis | Phase 1 | 2016-02-01 |
| Completed | A Study to Compare the Pharmacokinetics and Safety of a Fixed Dose Combination of Fimasartan/Amlodipine/Rosuva Hypertension, Hyperlipidemia | Phase 1 | 2015-09-01 |
| Completed | Long-term Immunogenicity and Safety of Fourth Administration of Boryung Cell-Culture Japanese Encephalitis Vac Japanese Encephalitis | Phase 4 | 2015-08-01 |
| Completed | The Drug-drug Interaction and Safety of Lafutidine and Irsogladine Maleate in Healthy Adult Volunteers Peptic Ulcer | Phase 1 | 2015-08-01 |
| Completed | A Study to Compare the Pharmacokinetics of Fimasartan/Atorvastatin Combination Tablet Hypertension, Hyperlipidemia | Phase 1 | 2015-08-01 |
| Completed | A Clinical Study to Evaluate the Pharmacokinetics of Lozanoc and Sporanox in Korean Healthy Male Volunteers Superficial Mycoses, Dermatomycoses, Candidiasis | Phase 1 | 2015-07-01 |
| Completed | Fimasartan Achieving SBP Target (FAST) Study Essential,Hypertension | Phase 4 | 2015-06-01 |
| Completed | Study to Evaluate the Pharmacokinetic Interaction Between Fimasartan and Atorvastatin in Healthy Male Voluntee Hypertension | Phase 1 | 2015-03-01 |
| Completed | Vaccine -diphthEria -tetaNus -Acellular pertUssis-inactivated polioviruS Diphtheria, Tetanus, Pertussis | Phase 3 | 2015-02-02 |
| Completed | Study to Evaluate the Pharmacokinetic Interaction and Safety After Multiple Oral Doses of Fimasartan/Amlodipin Hypertension | Phase 1 | 2015-02-01 |
| Completed | A Clinical Trial to Evaluate Efficacy, Tolerability, and Pharmacokinetic-Pharmacodynamic Relationship of Fimas Hypertension | Phase 2 | 2014-10-01 |
| Completed | A Randomized, Double-blind, Multicenter, Phase III Study to Evaluate the Efficacy and Safety of Combination of Essential Hypertension, Dyslipidemia | Phase 3 | 2014-08-01 |
| Completed | to Compare the Pharmacokinetics and Safety of Fimasartan/Rosuvastatin Combination Tablet and Coadministration Hypertension | Phase 1 | 2014-07-01 |
| Completed | To Compare the Pharmacokinetics of Fimasartan/Amlodipine Combination Tablet and Coadministration of Fimasartan Hypertension | Phase 1 | 2014-07-01 |
| Completed | Clinical Characteristics and Medication Satisfaction of Kanarb Tablet in Korean Hypertensive Patient(Kanarb-Hy Hypertension | — | 2014-07-01 |
| Completed | Fimasartan/Amlodipine Combination Phase III Essential Hypertension | Phase 3 | 2014-04-01 |
| Completed | To Evaluate the Pharmacokinetic Interactions and Safety Between Fimasartan and Rosuvastatin Hypertension | Phase 1 | 2013-08-01 |
| Completed | A Valsartan 80 Mg-Referenced, Therapeutic Exploratory Clinical Study to Evaluate the Antihypertensive Efficacy Essential Hypertension | Phase 2 | 2013-05-01 |
| Completed | Post-Authorization Long-term Safety Surveillance on Antihypertensive Treatment With Kanarb® (Fimasartan) Essential Hypertension | — | 2013-05-01 |
| Completed | Clinical Study to Evaluate the Antihypertensive Efficacy and Changes of Neurohormonal Markers of Fimasartan an Hypertension | Phase 4 | 2012-10-01 |
| Completed | Clinical Trials for Single Oral Dose of 60mg Fimasartan and Single IV Infusion of 30mg Fimasartan to Evaluate Healthy | Phase 1 | 2012-06-01 |
| Completed | A Multicenter, Phase 3 Study to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan(BR-A-657∙K) 30 Hypertension | Phase 3 | 2012-04-01 |
| Completed | Efficacy of fimaSartan on arTerIal stiFFness iN patiEntS With HypertenSion Hypertension | — | 2012-04-01 |
| Completed | A Multi-center, Randomized, Double-blind Phase III Clinical Trial to Assess and Compare to the Efficacy and Sa Erosive Esophagitis | Phase 3 | 2011-11-01 |
| Completed | A Randomized, Double-Blind, Placebo-Controlled, 3x3 Factorial Design, Phase II Study to Evaluate the Antihyper Hypertension | Phase 2 | 2011-08-01 |
| Completed | Pharmacokinetics of Megace F and Megace OS Under Fasting and Fed Conditions in Healthy Male Volunteers Cachexia, Anorexia | Phase 1 | 2011-07-01 |
| Completed | A Clinical Study to Evaluate Efficacy and Safety of Fimasartan/Hydrochlorothiazide Combination-therapy Essential Hypertension | Phase 3 | 2010-11-01 |
| Completed | Clinical Trial to Assess the Immunogenicity and Safety of the Vero Cell-derived JE Vaccine in Korea Japanese Encephalitis | Phase 3 | 2010-08-01 |
| Completed | A Clinical Trial to Compare and Evaluate the Pharmacokinetic Characteristics and the Safety of Fimasartan in R Renal Impairment | Phase 1 | 2010-06-01 |
| Completed | A Clinical Trial to Compare and Evaluate the Pharmacokinetic Characteristics and the Safety of Fimasartan in H Essential Hypertension, Hepatic Impairment | Phase 1 | 2010-05-01 |
| Completed | The Clinical Study to Evaluate the Efficacy and Safety of Fimasartan in Patients With Mild to Moderate Essenti Hypertension | Phase 3 | 2010-04-01 |
| Completed | A Study to Assess Food Effect on the Pharmacokinetics of Fimasartan in Healthy Male Volunteers Healthy | Phase 1 | 2009-10-01 |
| Completed | A Study to Evaluate the Effect of Fimasartan on Pharmacokinetics, and the Safety of Digoxin in Healthy Male Vo Essential Hypertension | Phase 1 | 2009-08-01 |
| Completed | A Clinical Trial to Evaluate the Effect of Fimarsartan on Pharmacodynamics, Pharmacokinetics, and the Safety o Essential Hypertension | Phase 1 | 2009-07-01 |
| Completed | A Study to Evaluate the Effect of Atorvastatin on the Pharmacokinetics of Fimasartan in Healthy Male Volunteer Essential Hypertension | Phase 1 | 2009-07-01 |
| Completed | A Study to Evaluate the Pharmacokinetic Drug Interaction After Oral Concurrent Administration of Fimasartan an Essential Hypertension | Phase 1 | 2009-06-01 |
| Completed | A Study to Evaluate the Effect of Ketoconazole and Rifampicin on the Pharmacokinetics of Fimasartan in Healthy Essential Hypertension | Phase 1 | 2009-04-01 |
| Completed | A Study to Evaluate the Safety and Pharmacokinetics After Oral Concurrent Administration of Fimasartan and Hyd Essential Hypertension | Phase 1 | 2009-03-01 |
| Completed | Study to Compare and Assess the Safety and Pharmacokinetic Characteristics After Oral Administration of Fimasa Essential Hypertension | Phase 1 | 2009-01-01 |
| Completed | Clinical Study to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan in Hypertension Patients Hypertension | Phase 3 | 2008-12-01 |
| Completed | A Therapeutic Exploratory Clinical Study to Evaluate the Antihypertensive Efficacy of Fimasartan (BR-A-657•K) Essential Hypertension | Phase 2 | 2008-12-01 |
| Completed | Antihypertensive Efficacy and Tolerability and Determine the Adequate Antihypertensive Dosage of Fimasartan in Hypertension | Phase 2 | 2007-09-01 |
| Completed | Administration Time-dependent Antihypertensive Effects of Low Dose Aspirin in Well-controlled Hypertensive Pat Well-controlled Hypertension | Phase 4 | 2006-09-01 |
| Completed | The Effects of Cilnidipine on Metabolic Syndrome Improvement Hypertension, Metabolic Syndrome X | Phase 4 | 2005-07-01 |
| Completed | Efficacy, Safety and Pharmacodynamic/Pharmacokinetic Study of Fimasartan (BR-A-657•K) Essential Hypertension | Phase 2 | 2005-04-01 |
| Completed | Cilnidipine Effect on High Blood Pressure and Cerebral Perfusion in Ischemic Stroke Patients With Hypertension Hypertension, Stroke | Phase 3 | 2005-01-01 |
| Completed | Fimasartan (BR-A-657) Multiple Oral Dose in Healthy Subjects Essential Hypertension | Phase 1 | 2004-01-01 |
| Completed | Fimasartan (BR-A-657) Single Oral Dose in Healthy Subjects Essential Hypertension | Phase 1 | 2003-09-01 |